Integer (NYSE:ITGR) Releases Quarterly Earnings Results, Misses Estimates By $0.34 EPS

Integer (NYSE:ITGR) released its quarterly earnings data on Thursday. The medical equipment provider reported $1.34 earnings per share for the quarter, missing the consensus estimate of $1.68 by ($0.34), FiscalAI reports. The firm had revenue of $449.66 million during the quarter, compared to analyst estimates of $456.91 million. Integer had a net margin of 6.97% and a return on equity of 12.79%. The business’s revenue for the quarter was down 3.8% on a year-over-year basis. During the same period in the prior year, the firm earned $1.79 earnings per share.

Integer Price Performance

Shares of ITGR stock opened at $126.56 on Friday. Integer has a twelve month low of $62.00 and a twelve month high of $126.83. The company has a market capitalization of $4.30 billion, a PE ratio of 34.58, a price-to-earnings-growth ratio of 2.41 and a beta of 0.58. The company has a current ratio of 3.73, a quick ratio of 2.41 and a debt-to-equity ratio of 0.75. The firm has a fifty day simple moving average of $126.21 and a 200-day simple moving average of $100.61.

Insider Buying and Selling at Integer

In other Integer news, insider Andrew Senn sold 9,408 shares of the stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $126.30, for a total transaction of $1,188,230.40. Following the transaction, the insider owned 5,405 shares of the company’s stock, valued at $682,651.50. This trade represents a 63.51% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Kirk Thor sold 11,767 shares of the business’s stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $126.23, for a total transaction of $1,485,348.41. Following the sale, the insider directly owned 7,153 shares of the company’s stock, valued at approximately $902,923.19. This represents a 62.19% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 40,948 shares of company stock worth $5,169,920 over the last ninety days. 1.10% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

ITGR has been the subject of several research reports. Zacks Research upgraded shares of Integer from a “strong sell” rating to a “hold” rating in a research note on Monday, July 20th. Freedom Capital downgraded shares of Integer from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 4th. Oppenheimer lowered shares of Integer from an “outperform” rating to a “market perform” rating in a report on Monday, August 3rd. Weiss Ratings raised shares of Integer from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, October 23rd. Finally, Citigroup increased their price target on Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a report on Wednesday, July 8th. One research analyst has rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $113.67.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global medical device and advanced energy technology company. It partners with original equipment manufacturers to design and manufacture components, subassemblies and finished products used in minimally invasive and implantable medical devices.

Its medical technologies include batteries and power systems for pacemakers, implantable cardioverter-defibrillators, neurostimulators and drug-delivery systems, as well as catheter and guidewire components, coated wire, electrodes and other products used in cardiovascular, neuromodulation and other medical applications.

Integer also develops specialty batteries and power solutions for markets such as energy, aerospace and defense.